Published ahead of print on April 24, 2003, doi:10.1165/rcmb.2002-0247OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 410-418, 2003
© 2003 American Thoracic Society DOI: 10.1165/rcmb.2002-0247OC
Adenosine Receptors and Phosphodiesterase Inhibitors Stimulate Cl- Secretion in Calu-3 Cells
Bryan R. Cobb,
Lijuan Fan,
Timea E. Kovacs,
Eric J. Sorscher and
John P. Clancy
Departments of Human Genetics, Medicine, and Pediatrics, and Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama
Address correspondence to: Dr. J. P. Clancy, M.D., Associate Professor, Department of Pediatrics, Associate Scientist, Gregory Fleming James Cystic Fibrosis Research Center, 1600 7th Avenue South, Suite 620 ACC, Birmingham, AL 35233. E-mail: jclancy{at}peds.uab.edu
We investigated cystic fibrosis transmembrane conductance regulator (CFTR) activation by clinically used phosphodiesterase inhibitors (PDEis) in Calu-3 cell monolayers alone and in combination with A2B adenosine receptor stimulation. This receptor pathway has previously been shown to activate wild-type and mutant CFTR molecules. Several PDEis, including milrinone, cilostazol (Pletal), papaverine, rolipram, and sildenafil (Viagra), produced a short circuit current (Isc) that was glibenclamide-sensitive, achieving 2085% of forskolin-stimulated Isc. Papaverine, cilostazol, and rolipram also augmented both the magnitude and the duration of Isc following low dose stimulation of adenosine receptors with Ado (0.11.0 µM, P < 0.01). Subsequent studies demonstrated that very low concentrations of cilostazol or papaverine ( 1/2 peak serum concentrations) were sufficient to activate Isc, and both agents markedly augmented Ado-stimulated Isc (1 µM, P < 0.01). Our results provide evidence that select PDEis, at concentrations achieved as part of systemic therapies, can activate CFTR-dependent Isc in Calu-3 cell monolayers. These studies also indicate that PDEis have the capacity to augment an endogenous CFTR-activating pathway in an "in vivo"like model system, and supports future investigations of these agents relevant to cystic fibrosis.
Abbreviations: adenosine deaminase, ADA cystic fibrosis, CF cystic fibrosis transmembrane conductance regulator, CFTR cilostazol, Cil 8-Cyclopentyl-1,3-dipropylxanthine, DPCPX hexokinase, HEXO short circuit current, Isc milrinone, Mil papaverine, Pap phosphodiesterase, PDE PDE inhibitor, PDEi rolipram, Rol theophylline, Theo
This article has been cited by other articles:

|
 |

|
 |
 
B. M. Rollins, M. Burn, R. D. Coakley, L. A. Chambers, A. J. Hirsh, M. T. Clunes, M. I. Lethem, S. H. Donaldson, and R. Tarran
A2B Adenosine Receptors Regulate the Mucus Clearance Component of the Lung's Innate Defense System
Am. J. Respir. Cell Mol. Biol.,
August 1, 2008;
39(2):
190 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, Y. Sun, W. Zhang, and P. Huang
Apical adenosine regulates basolateral Ca2+-activated potassium channels in human airway Calu-3 epithelial cells
Am J Physiol Cell Physiol,
June 1, 2008;
294(6):
C1443 - C1453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun, F. Wu, F. Sun, and P. Huang
Adenosine Promotes IL-6 Release in Airway Epithelia
J. Immunol.,
March 15, 2008;
180(6):
4173 - 4181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Clarke
Phosphodiesterase 5 Inhibitors and Cystic Fibrosis: Correcting Chloride Channel Dysfunction
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
469 - 470.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lubamba, H. Lecourt, J. Lebacq, P. Lebecque, H. De Jonge, P. Wallemacq, and T. Leal
Preclinical Evidence that Sildenafil and Vardenafil Activate Chloride Transport in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
506 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Moeller, F Horak Jr, C Lane, D Knight, A Kicic, S Brennan, P Franklin, J Terpolilli, J H Wildhaber, and S M Stick
Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis
Thorax,
June 1, 2006;
61(6):
514 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, W. Wang, W. Parker, and J. P. Clancy
Adenosine Regulation of Cystic Fibrosis Transmembrane Conductance Regulator through Prostenoids in Airway Epithelia
Am. J. Respir. Cell Mol. Biol.,
May 1, 2006;
34(5):
600 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Palmer, S. Y. Lee, P. J. Maniak, D. Carlson, S. C. Fahrenkrug, and S. M. O'Grady
Protease-activated receptor regulation of Cl- secretion in Calu-3 cells requires prostaglandin release and CFTR activation
Am J Physiol Cell Physiol,
April 1, 2006;
290(4):
C1189 - C1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Bebok, J. F. Collawn, J. Wakefield, W. Parker, Y. Li, K. Varga, E. J. Sorscher, and J. P. Clancy
Failure of cAMP agonists to activate rescued {Delta}F508 CFTR in CFBE41o- airway epithelial monolayers
J. Physiol.,
December 1, 2005;
569(2):
601 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Liu, A. Veilleux, L. Zhang, A. Young, E. Kwok, F. Laliberte, C. Chung, M. R. Tota, D. Dube, R. W. Friesen, et al.
Dynamic Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Type 3 and Type 4D Phosphodiesterase Inhibitors
J. Pharmacol. Exp. Ther.,
August 1, 2005;
314(2):
846 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Barnes, G. Livera, P. Huang, C. Sun, W. K. O'Neal, M. Conti, M. J. Stutts, and S. L. Milgram
Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium
J. Biol. Chem.,
March 4, 2005;
280(9):
7997 - 8003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Lazarowski, R. Tarran, B. R. Grubb, C. A. van Heusden, S. Okada, and R. C. Boucher
Nucleotide Release Provides a Mechanism for Airway Surface Liquid Homeostasis
J. Biol. Chem.,
August 27, 2004;
279(35):
36855 - 36864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hentchel-Franks, D. Lozano, V. Eubanks-Tarn, B. Cobb, L. Fan, R. Oster, E. Sorscher, and J. P. Clancy
Activation of Airway Cl- Secretion in Human Subjects by Adenosine
Am. J. Respir. Cell Mol. Biol.,
August 1, 2004;
31(2):
140 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-N. Wu, S.-I. Liu, and M.-H. Huang
Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH3 Cells and Pheochromocytoma PC12 Cells
Endocrinology,
March 1, 2004;
145(3):
1175 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Bucheimer and J. Linden
Purinergic regulation of epithelial transport
J. Physiol.,
March 1, 2004;
555(2):
311 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|